Acquired perforating dermatoses represent an uncommon group of chronic papulonodular dermatoses of unknown aetiology, characterized clinically by intense itching; and histopathologically by transepidermal elimination of dermal components. Definitive targeted pharmacological approaches are lacking, and the disease is usually refractory to therapy. We report here a case of rapid remission of acquired perforating dermatosis following simple thymectomy. If a role for the thymus in the pathogenesis of acquired perforating dermatoses was to be established, this could pave the way for a yet uncharted surgical therapy for these debilitating conditions.
SarayYSeçkinDBilezikçiB. Acquired perforating dermatosis: Clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol2006; 20: 679–688.
2.
HarbaouiSLitaiemN. Acquired perforating dermatosis. In: StatPearls. Treasure Island, FL: StatPearls Publishing, 2022. Updated 17 February 2022. https://www.ncbi.nlm.nih.gov/books/NBK539715/.
3.
LyndeCBPrattMD. Clinical images: acquired perforating dermatosis: Association with diabetes and renal failure. CMAJ2009; 181: 615.
4.
FernandesKALimaLAGuedesJC,et al.Acquired perforating dermatosis in a patient with chronic renal failure. An Bras Dermatol2016; 91: 10–13.
5.
ImamTHPatailHKhanN,et al.Acquired perforating dermatosis in a patient on peritoneal dialysis: A case report and review of the literature. Case Rep Nephrol2018; 2018: 5953069.
6.
FritzeDHerrmannC. Leukocyte and lymphoid cell counts in myasthenia gravis. Neurology1975; 25: 251.
